James Merson - 18 Jun 2025 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: Director
Signature: /s/ Shane Ward, Attorney-in-Fact
Issuer symbol: CDTX
Transactions as of: 18 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 18 Jun 2025, 17:04:37 UTC
Previous filing: 19 Jul 2024
Next filing: 07 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Merson James	Director	C/O CIDARA THERAPEUTICS, INC., 6310 NANCY RIDGE DRIVE SUITE 101, SAN DIEGO	/s/ Shane Ward, Attorney-in-Fact	18 Jun 2025	0002020898

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Stock Option (right to buy)	Award	$0	+11,100		$0.000000	11,100	18 Jun 2025	Common Stock	11,100	$21.31	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option shall vest on the earlier of (i) June 18, 2026 or (ii) the day prior to the date of the Issuer's 2026 annual meeting of stockholders.